Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
ARMO BioSciences (ARMO) | Jefferies/ Leerink Partners/ BMO Capital Markets | $86.25 | n.a. | |||
DFB Healthcare Acquisitions (TBA) (u) | Goldman Sachs/ Deutsche Bank Securities | 25.00 | $10.00 | $10.00 | $250.00 | n.a. |
Gates Industrial Corporation plc (GTES) | Citigroup/ Morgan Stanley/ UBS Investment Bank | $100.00 | n.a. | |||
Menlo Therapeutics (MNLO) | Jefferies/ Piper Jaffray/ Guggenheim Securities | $97.75 | n.a. | |||
PagSeguro Digital Ltd. (PAGS) | Goldman Sachs/ Morgan Stanley | $100.00 | n.a. | |||
resTORbio (TORC) | BofA Merrill Lynch/ Leerink Partners/ Evercore ISI | $85.00 | n.a. | |||
Solid Biosciences (SLDB) | J.P. Morgan/ Goldman Sachs/ Leerink Partners | $100.00 | n.a. | |||
n.a. (not available) | ||||||
TBA (to be announced) | ||||||
u (unit offering) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
None | ||||||
New Terms | ||||||
None | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Dec. 25, 2017 | Manager(s) | Offered | Raised | Price | 12/29/17 | Change |
None |